Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
761.930.02%
QQQ
707.830.03%
BTC/USD
77314.780.1005%
DIA
527.670.02%
GLD
396.500.06%
TLT
81.830.05%

Tectonic Therapeutic Inc

TECXNASDAQ
Trade with Public
Trade with Public
$31.22
1.284.28%
At close: Sep 1, 5:00 PM EST
$30.60
-0.62-1.99%
After Hours: 5:47 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Tectonic Therapeutic Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tectonic Therapeutic (TECX).

Price Target Range — 9 Quarters

Analyst Consensus — 10 Analysts

1S.Buy
9Buy
Consensus RatingOutperform# Analysts10Avg. Consensus PT$77Upside to Avg. PT+152.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 7, 2026Wells FargoTiago FauthPT CutOverweight$101→$93
May 26, 2026Raymond JamesMichael FreemanUpgradeOutperform→Strong Buy$76→$81
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and lowers the price target from $101 to $93.
Benzinga Newsdesk

PRO
Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81

Raymond James analyst Michael Freeman upgrades Tectonic Therapeutic (NASDAQ:TECX) from Outperform to Strong Buy and raises the price target from $76 to $81.
Benzinga Newsdesk

PRO
Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75

Stifel analyst James Condulis initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and announces Price Target of $75.
Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60

Truist Securities analyst Danielle Brill maintains Tectonic Therapeutic (NASDAQ:TECX) with a Buy and lowers the price target from $64 to $60.
Benzinga Newsdesk

PRO
Oppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $80

Oppenheimer analyst Leland Gershell initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Outperform rating and announces Price Target of $80.
Benzinga Newsdesk

PRO
Truist Securities Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $64

Truist Securities analyst Danielle Brill initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and announces Price Target of $64.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved